共 50 条
- [21] Real-world healthcare costs and resource utilization (HRU) among patients treated with erenumab in the United States: A retrospective claims database study JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 17 - 18
- [28] Real-World Treatment Patterns and Clinical Outcomes in Advanced Gastrointestinal Neuroendocrine Tumors (GI NET): A Multicenter Retrospective Chart Review Study ONCOLOGIST, 2019, 24 (08): : 1056 - 1065
- [29] A real-world, observational study of erenumab for migraine prevention in Canadian patients with prior prophylactic treatment failure HEADACHE, 2022, 62 : 131 - 132